# A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

> **NCT00708201** · PHASE4 · COMPLETED · sponsor: **Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 280 (actual)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** Alvimopan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00708201
- **Lead sponsor:** Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2016-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708201, "A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00708201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*